Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
Atherosclerotic cardiovascular disease (ASCVD) affects a substantial proportion of adults with β-thalassaemia. It appears to be driven by conventional CV risk factors rather than disease-specific features, according to research presented at EHA2026.
ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026
Izokibep maintains PsA efficacy at 52 weeks
The novel small-protein IL-17 inhibitor izokibep demonstrates durable efficacy and a favourable safety profile over 52 weeks in patients with active psoriatic arthritis (PsA), with sustained improvements in joint, skin, and quality-of-life outcomes in a phase IIB/III study.
Izokibep maintains PsA efficacy at 52 weeks
04 Aug 2026
Sexual desire trajectories vary during medically assisted reproduction
Trajectories of sexual desire tend to differ in couples with medical infertility undergoing medically assisted reproduction (MAR), and some types are better predicted by education and relationship satisfaction, suggests a recent study.






